Home » Topics » Regulatory » Patents

Patents
RSS

New treatment options for cardiovascular disorders imparted in recent patents

Jan. 23, 2007

Recent Merck, Ambrilia and AnorMED patents disclose novel therapeutics for HIV infection

Jan. 23, 2007

Recent Janssen and Aska patents report new therapeutic agents for urological disorders

Jan. 23, 2007

New agents for treating gastrointestinal disorders disclosed in recent patents

Jan. 22, 2007

Recent patents report novel analgesic agents

Jan. 22, 2007

New therapeutic agents for ocular disorders disclosed in recent patent literature

Jan. 22, 2007

Novel therapeutic agents for neurological disorders reported in recent patent literature

Jan. 19, 2007

Recent patents describe new therapeutic agents for depression, anxiety, psychosis et al.

Jan. 19, 2007

Recent patents disclose novel metabolic drugs

Jan. 19, 2007

Novel therapeutic agents for respiratory disorders disclosed in recent Argenta patents

Jan. 18, 2007

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.